Additionally, hesperetin decreases the main virulence factors, such as cytotoxin-associated antigen A (CagA) and vacuolytic cytotoxin A (VacA), and diminishes the translocation of CagA and VacA proteins into gastric adenocarcinoma cells (AGS) [1]. The gene discussed is S100A8; the disease is gastric adenocarcinoma.